SOUTHAMPTON, Pa., April 13, 2016 -- Quaint Oak Bancorp, Inc. (OTCQX:QNTO) (the "Company"), the holding company for Quaint Oak Bank, announced today that its Board of Directors at their meeting on April 13, 2016, declared a quarterly cash dividend of $0.04 per share on the common stock of the Company payable on May 9, 2016, to the shareholders of record at the close of business on April 25, 2016.
Robert T. Strong, President and Chief Executive Officer stated, “I am pleased to announce our seventh consecutive annual increase in our quarterly cash dividend to $0.04 per share, which represents a 6.7% increase in the dividend rate following our mid-year increase in October 2015. The increased dividend is a reflection of our positive financial performance for fiscal 2015 which ended on a very positive note with the fourth quarter and year-end earnings recorded as the highest earning quarter and year in our history. As always, our current and continued business strategy includes long term profitability and the payment of dividends. This focus reflects the Company’s strong commitment to shareholder value.”
Quaint Oak Bancorp, Inc. is the holding company for Quaint Oak Bank. Quaint Oak Bank is a Pennsylvania-chartered stock savings bank headquartered in Southampton, Pennsylvania and conducts business through its two regional offices located in the Delaware Valley and Lehigh Valley markets in Pennsylvania.
Statements contained in this news release which are not historical facts may be forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts. They often include words like “believe,” “expect,” “anticipate,” “estimate” and “intend” or future or conditional verbs such as “will,” “would,” “should,” “could” or “may.” We undertake no obligation to update any forward-looking statements.
Contact: Quaint Oak Bancorp, Inc. Robert T. Strong, President and Chief Executive Officer (215) 364-4059


FDA Approves Mitapivat for Anemia in Thalassemia Patients
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Italy Fines Apple €98.6 Million Over App Store Dominance
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 



